跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORSERDU 345 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ORSERDU 345 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ORSERDU 345 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Stemline Therapeutics B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 4, 2024
Approval ID
32ec1f03413b1c48
Company
Stemline Therapeutics B.V.
Type
Standard
Approval Details
Approval Id
32ec1f03413b1c48
Drug Cima Aemps Name
ORSERDU 345 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231757002
Holder Company Name
Stemline Therapeutics B.V.
Marketing Company Name
Menarini Stemline Espana S.L.
Holder Company Detail Path
/organization/stemline-therapeutics-bv
Authorization Date
2024-04-04
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
345 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Stemline Therapeutics B.V.
Company Detail Path
/organization/stemline-therapeutics-bv
Company Information
Pharmaceutical Company Name
Stemline Therapeutics BV
Country Name
Netherlands
Active Ingredients
ELACESTRANT DIHIDROCLORURO
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 4, 2024
Approval ID
32ec1f03413b1c48
Type
Standard
Back to CIMA-AEMPS Approvals
